¶¶Òõ¶ÌÊÓƵ

Meeting Objectives:

One of the main objectives of the symposium is to create an HPV community in the global south by engaging countries at different levels of HPV vaccination program introduction to:

• Share experiences and lessons learned
• Discuss evidence-based policies and program implementation in and across countries
• Contribute to  the research agenda to accelerate progress in HPV vaccine introduction, access, program optimization, restoration, and sustainability
• Discuss new developments in the field and health models that can be integrated with HPV vaccination programs
• Provide updated information on available data on HPV vaccine evaluation including schedules
• Discuss integration of HPV vaccination programs with adolescent health services.

Saturday, 24th September 2022

SESSION 1: INAUGURAL SESSION (, )​

• Welcome Note
  Honorable State Minister of Health Ethiopia
  HE Dr Dereje Duguma
  
  
• Welcome & Introduction
  CHIC SPC Secretariat
  Dr. Alex Vorsters, Dr. Nelly Mugo, Dr. Margaret Stanley (online)
  
  
• Co-host- FMOH Ethiopia
  Dr. Meseret Zelalem, Mr. Yohannes Lakew, Mr. Mengistu Bogale
  
  
• Co-host - Ethiopia Society of Gynaecology and Obstetrics (ESOG)
  Dr. Abdulfetah Abdulkadir (President ESOG)
  
  
• Participants Introduction
  
  

SESSION 2: CERVICAL CANCER PREVENTION LANDSCAPE
Chairs: Dr. Velepi Mtonga & Dr. Mario Poljak

• HPV related cancers incidence, mortality, social and economic impact in Africa
  Ms. Ann Korir (KEMRI, ACRN)
  (, , )
  
  
• HPV vaccination programs – regional overview
  Dr. Phionah Atuhebwe (WHO)
  (, , )
  
  
• Q&A 
  
  

SESSION 3: ENSURING EFFECTIVE INTRODUCTIONS: EXPERIENCES AND LESSONS LEARNED FROM DECISION-MAKING, PLANNING, AND PREPARATION OF HPV VACCINATION PROGRAMS
SESSION 3A: LOCAL DATA AVAILABILITY: DENOMINATOR DATA, DATA FOR PLANNING AND STRENGTHENING HEALTH INFORMATION SYSTEMS
Chairs:  Dr. Portia Manangazira (Director of Epidemiology and Disease Control at Ministry of Health & Child Care, Zimbabwe) & Dr. Driwale Alfred (Assistant Commissioner of Health Services: Vaccines & Immunization, Uganda)

Local data availability: denominator data, data for planning and strengthening health information systems

• Ethiopia Immunization Monitoring System
  Mr. Yohannes Lakew (EPI, MOH Ethiopia)
  (, , )
  
  
• Rwanda data availability: Denominator data, data for planning and strengthening health information systems
  Ms. Irene Mukanyandwi  (EPI, MOH Rwanda) - Online
  (, , )
  
  
• Q&A 
  
  
• Tracking, and follow-up – Lessons learned from other vaccination programs
  Mr. Kebba Touray & Ms. Marie Babona Nshuti (WHO)
  (, , )
  
  
• Local solutions for data generation, collection, and reporting/ improving health information systems for HPV vaccines 
  Q&A & Discussion
  
  
  

SESSION 3B: EXPERIENCES AND LESSONS LEARNED FROM DECISION-MAKING, PLANNING, AND PREPARATION OF HPV VACCINATION PROGRAMS
Chairs: Messeret Shibeshi (WHO) & Dr. Furaha Kyesi ( EPI, MOH, Tanzania)

• Timely preparedness assessment, associated challenges, and impact on planning
  Ms. Temwa Stella Mzengeza (Malawi Ministry of Health)
  (, , )​
  
  
• Importance of stakeholder inclusion and coordination in the planning and introduction of the HPV vaccination program in Côte d'Ivoire / Importance de l'inclusion et de la coordination des parties prenantes dans la planification et l'introduction du programme de vaccination contre le HPV en Côte d’Ivoire
  Dr. Innocent Massenon (Chargé de prestation à la Direction de Coordination du Programme Elargi de Vaccination)
  (, , )
  
  
• Q&A 
  
  

SESSION 3C: GAVI APPLICATION PROCESS: PROCESS, BOTTLE NECKS AND LESSONS LEARNED
Chairs: Dr. Landry Kaucley (EPI Manager, Benin) & Dr. Kwame Amponsa Achiano (EPI Manager, Ghana)

GAVI application process, challenges and lessons learned

• Mozambique's Experience with the Introduction of the HPV Vaccine
  Ms. Amelia Dipuve (EPI, MOH Mozambique)
  (, )
  
  
• GAVI application process, challenges and lessons learned
  Dr. Landry Kaucley (EPI Manager, Benin)
  (, , )
  
  
• Q&A 
  
  

SESSION 3D: PANEL DISCUSSION ON TIMELY PLANNING AND THE IMPORTANCE OF IMPROVING PARTNERSHIPS
Chairs: Rose Dlamini ( WHO WR Ethiopia) & Ms. Sarah Wanyoike (Jhpiego)

• HPV Vaccination Program Introduction Challenges; An overview from National Stakeholders
  Dur-e-Nayab Waheed (University of Antwerp) & Dominique Guillaume (John Hopkins University School of Nursing, Jhpiego)
  (, , )
  
  
• Planning framework, human resource, and stakeholders’ inclusion/ Timely planning and improving partnerships
  Panelists: Dr. Furaha Kyesi (EPI, MOH, Tanzania),  Colline Chigodo (EPI Zimbabwe), Dr. Francis Dien Mwansa (MOH  Zambia)  Lucy Kiari (JSI), Dr. Driwale Alfred (EPI, Uganda), Ms Temwa Mzengeza (EPI, Malawi), Chris Morgan (Jhpiego)
  ()
  
  

SESSION 4A: PROGRAMMATIC CONSIDERATION - DOSING SCHEDULES: GUIDELINES, NEW STRATEGIES, AND FUTURE APPROACHES
Chairs: Dr. Nelly Mugo (KEMRI, Kenya) & Prof. Margaret Stanley (University of Cambridge, UK)

• Efficacy of single-dose HPV vaccination among young African women (KEN SHE)
  Dr. Maricianah Onono (Kenya)
  (, , )
  
  
• One dose trial data
  Dr. Deborah Watson-Jones (Tanzania) - Online
  (Pdf, , )
  
  
• Q&A 
  
  
• One dose: current guidelines, available vaccines and opportunities for MAC catchup programs with one dose
  Dr. Hiroki Akaba (WHO)
  (, , )
  
  
• One dose decision making in Nigeria
  A progress toward successful HPV Introduction and accelerating coverage in Nigeria
  Dr. Garba Bakunawa (NHPCDA, Nigeria)
  (, , )
  
  
• Q&A 
  
  

SESSION 4B: PROGRAMMATIC CONSIDERATIONS: DELIVERY PLATFORMS AND NEW STRATEGIES, AND FUTURE APPROACHES
Chairs Dr. Anissa Sidibe (GAVI) – Online & Dr. Deborah Watson Jones (Tanzania)

HPV Vaccine Delivery:  What are current delivery strategies? How are countries restoring coverage following Covid-19 interruptions

• The Gambia HPV Vaccine Delivery; current delivery strategy and plans for restoring coverage following Covid-19 interruption
  Ms. Mamanding Kinteh (EPI Focal person, The Gambia)
  (, , )
  
  Mr. Eric Chisupa (EPI Zambia)
  (, , )
  
  
• HPV Vaccine delivery strategies Kenya
  Ms. Christine Miano  (EPI, Kenya)
  (, , )
  
  
• HPV Vaccine Delivery - Liberia
  Dr. Adolphus Clark (EPI Manager, Liberia)
  ()
  
  
• Discussion on delivery strategies: Are school based programs sustainable? How HPV vaccine delivery platforms can be made sustainable?
  (, )
  
  
• Introduction during Covid-19: implications and strategies to tackle interruptions. The case of Cameroon
  Dr. Andreas Njoh Ateke (EPI, Cameroon)
  (, , )
  
  
• Q&A 
  
  

Sunday, 25 September 2022

DAY 2: INTRODUCTION

• Welcome Note for Day 2
  WHO WR Ethiopia
  (, )
  
  

SESSION 5: ADVOCACY, COMMUNICATION, AND SOCIAL MOBILIZATION AMONG HEALTH WORKFORCE FOR HPV VACCINATION
Chairs: Sabrina Kitaka (Makerere University, Uganda) & Zoey Diaz (BMGF)

• HPV communication plan: crisis management plan, needs and lessons learnt/ Plan de communication HPV: Gestion des crises et leçons apprises (Le cas du Sénégal)
  Mrs. Raabi Diouf (UNICEF, Senegal)
  (, , )
  

Communication for health work force at the district level: approaches and challenges

• HPV Communication for healthcare workers at facility level: Approaches and challenges
  Rosemary Njura Njogu (Jhpiego, Kenya)
  (, , )
  
  
• Social Mobilization and advocacy in Sebeta, Ethiopia
  Mrs. Belaynesh Mekonnen (Healthcare professional, Ethiopia)
  (, , )
  
  
• Discussion 
  
  

SESSION 6A: TRAINING AND SENSITIZATION OF STAKEHOLDERS INVOLVED IN DECISION-MAKING, PLANNING AND IMPLEMENTATION
Chairs: Dr. Mutale Mumba (WHO) & Mengistu Bogale (EPI, MOH Ethiopia)

• Training and Sensitization: A critical aspect of a vaccination program and implication on HPV vaccination programs
  Mengistu Bogale (EPI, MOH Ethiopia)
  (, , )​
  
  
• Discussion 
  
  

SESSION 6B: TRAINING OF HEALTH WORKFORCE (VACCINATORS/HEALTHCARE PROFESSIONALS/ FRONT LINE WORKERS
Chairs: Dr. Mutale Mumba (WHO) & Dur-e-Nayab Waheed (University of Antwerp)

• Training of healthcare professionals(HCP) at the district level; challenges and gaps
  Thomas Lweya  (EPI coordinator for Ntchisi district, Malawi)
  (, , )
  
  
• Optimizing training approaches: considerations for program implementers
  Joseph Rujumba (Makerere University, Uganda)
  (, , )
  
  
• Discussion 
  
  

SESSION 7: SUSTAINABILITY AND RESTORING HPV VACCINATION PROGRAMS
Chairs: Cathy Ndiaye (PATH) & Christopher Morgan (Jhpiego)

HPV vaccine delivery strategy, how to move towards sustainable delivery platforms and the facilitators to achieve sustainable coverage

• HPV vaccine delivery strategy in Tanzania - Towards sustainable delivery platforms and coverage
  Dr. Florian Tinuga ( EPI, MOH, Tanzania) 
  (, , )
  
  Dr. Meseret Zelalem (MCHND Director, Federal Ministry of Health Ethiopia)
  (, , )
  
  
• Intensifying immunization of girls aged 9-14 years as a mitigation strategy for COVID- 19 on HPV Vaccination: Experience in Côte d'Ivoire/ Intensification de la vaccination des filles de 9-14 ans comme stratégie d’atténuation des effets de la COVID-19sur la vaccination contre le HPV : Expérience de la Côte d’Ivoire
  Kouakou Seraphin (Jhpiego, Cote d’Ivoire)
  (, , )
  
  
• Q&A 
  
  
• Opportunities for integrating HPV vaccination program with adolescent health services
  Clarence Mbanga (CHAI, Cameroon)
  (, , )
  
  
• Q&A 
  
  

SESSION 8: CERVICAL CANCER ELIMINATION PARTNERS LANDSCAPE AND THEIR ACTIVITIES
Chairs: Dr. Vellepi Mtonga & Dr. Yirgu Gebrehiwot

• Public Health Initiative Liberia
  Ms. Joyce L. Kilikpo Jarwolo
  (, , )
  
  
• DREAMS project Malawi
  Ms. Getrude Chipungo
  (, , )
  
  
• UICC’s Role in Cervical Cancer Elimination
  Her Excellency Dr Zainab Shinkafi Bagudu  
  (, , )
  
  
• The African Cancer Registry Network
  Ms. Ann Korir
  (, , )
  
  
• The Kebbi integrated approach PHC revival and cancer control.
  Dr. Abubakar Dan Kaoje
  (, , )
  
  
• Discussion 
  
  

SESSION 9: BREAKOUT GROUPS
Chairs: University of Antwerp Team

• Breakout group 1: Professional associations and their role in planning, implementation and scale-up of HPV vaccination programs, the existing challenges and the way forward
  Chairs:
  
• Breakout group 2: NGOs and Implementers and their role in planning, implementation and scale-up of HPV vaccination programs, the existing challenges and the way forward
  Chairs:
• Breakout group 3: MOH & Global partners  –  their role in planning, implementation and scale-up of HPV vaccination programs, the existing challenges and the way forward
  Chairs:
  
• Plenary feedback per group in the main session (, )
  
  

​SESSION 10: CONCLUSIONS
Chairs: Prof. Dr. Mathuram Santosham (John Hopkins University) & Prof. Dr. Alex Vorsters (University of Antwerp)

• Conclusion and concluding remarks
  (, )